Yi Junxuan,Wang Rui,Wei Xinfeng,Wang Mingwei,Jin Shunzi.Research progress of RNA m6A modification in malignant tumor and its mechanism of radiotherapy[J].Chinese Journal of Radiological Medicine and Protection,2021,41(3):234-240
Research progress of RNA m6A modification in malignant tumor and its mechanism of radiotherapy
Received:November 30, 2020  
DOI:10.3760/cma.j.issn.0254-5098.2021.03.014
KeyWords:N6-methyladenosine modification  Writers  Erasers  Readers  Radiation Therapy
FundProject:国家自然科学基金面上项目(81872550, 81573085)
Author NameAffiliationE-mail
Yi Junxuan Key Laboratory of Radiobiology, National Health Commission, School of Public Health, Jilin University, Changchun, 130021, China  
Wang Rui Key Laboratory of Radiobiology, National Health Commission, School of Public Health, Jilin University, Changchun, 130021, China  
Wei Xinfeng Key Laboratory of Radiobiology, National Health Commission, School of Public Health, Jilin University, Changchun, 130021, China  
Wang Mingwei Key Laboratory of Radiobiology, National Health Commission, School of Public Health, Jilin University, Changchun, 130021, China  
Jin Shunzi Key Laboratory of Radiobiology, National Health Commission, School of Public Health, Jilin University, Changchun, 130021, China jinsz@jlu.edu.cn 
Hits: 2139
Download times: 1073
Abstract::
      N6-methyladenosine (m6A) is the most abundant RNA base modification in mammals, especially in eukaryotic messenger RNA (mRNA). N6-methyladenosine modification can regulate RNA splicing, translocation, stability and ultimately affect protein synthesis. m6A modification is catalyzed by RNA writers, reduced by erasers and also be recognized by readers. Abnormal changes ofm6A levels are closely related to tumor occurrence and development, including proliferation, growth, invasion and metastasis. In the process of tumor radiotherapy, m6A modification affects the efficacy of radiotherapy by affecting DNA damage, tumor stem cell generation and tumor cell radiation sensitivity. This article reviews the role of m6A-modified epigenetic regulation in malignant tumors and the research progress of its mechanism in tumor radiotherapy, in order to provide new ideas for the development of clinical tumor molecular targeted therapies and radiosensitizers.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9057107  On-line:0

v
Scan QR Code
&et=FC9DA7BF2F842A3BAE24B54F70914FE6292FB670D3333124B2783C53D952297F03D658039062BD478478D24ADD1CC2B96CD672B518193930E3391BB0110E05972E587C2DBF72947E361541E7391BE69673A2E22A56BF5E6D4694F02D49CD9CAFB060651877B69A622A7C8108901B082D&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9475FABC7A03F4AB&aid=A575E7A487BCD0A6F4E33AED7ABAA88F&vid=&iid=38B194292C032A66&sid=D9AE183D3F5C3C75&eid=C812B90E96151014&fileno=20210314&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9475FABC7A03F4AB"; var my_aid="A575E7A487BCD0A6F4E33AED7ABAA88F";